SK BIOPHARMACEUTICALS earnings per share and revenue

326030 earnings per share for the last quarter are 123.44 KRW whereas the estimation was 123.44 KRW which accounts for 0.00% surprise. Company revenue for the same period amounts to 131.15 B KRW despite the estimated figure of 131.49 B KRW. Estimated earnings per share for the next quarter are 67.49 KRW, and revenue is expected to reach 145.11 B KRW. Also watch annual changes over time to get a bigger picture of 326030 earnings per share and revenue dynamics.